191 related articles for article (PubMed ID: 19182823)
1. Epstein-Barr virus LMP2A accelerates MYC-induced lymphomagenesis.
Bultema R; Longnecker R; Swanson-Mungerson M
Oncogene; 2009 Mar; 28(11):1471-6. PubMed ID: 19182823
[TBL] [Abstract][Full Text] [Related]
2. Epstein-Barr virus LMP2A bypasses p53 inactivation in a MYC model of lymphomagenesis.
Bieging KT; Amick AC; Longnecker R
Proc Natl Acad Sci U S A; 2009 Oct; 106(42):17945-50. PubMed ID: 19815507
[TBL] [Abstract][Full Text] [Related]
3. Two Pathways of p27
Sora RP; Ikeda M; Longnecker R
mBio; 2019 Apr; 10(2):. PubMed ID: 30992353
[TBL] [Abstract][Full Text] [Related]
4. Latent membrane proteins from EBV differentially target cellular pathways to accelerate MYC-induced lymphomagenesis.
Ikeda M; Hayes CK; Schaller SJ; Longnecker R
Blood Adv; 2022 Jul; 6(14):4283-4296. PubMed ID: 35605249
[TBL] [Abstract][Full Text] [Related]
5. EBV latent membrane protein 2A orchestrates p27
Fish K; Sora RP; Schaller SJ; Longnecker R; Ikeda M
Blood; 2017 Dec; 130(23):2516-2526. PubMed ID: 29074502
[TBL] [Abstract][Full Text] [Related]
6. Epstein-Barr virus in Burkitt's lymphoma: a role for latent membrane protein 2A.
Bieging KT; Swanson-Mungerson M; Amick AC; Longnecker R
Cell Cycle; 2010 Mar; 9(5):901-8. PubMed ID: 20160479
[TBL] [Abstract][Full Text] [Related]
7. Rapamycin reverses splenomegaly and inhibits tumor development in a transgenic model of Epstein-Barr virus-related Burkitt's lymphoma.
Cen O; Longnecker R
Mol Cancer Ther; 2011 Apr; 10(4):679-86. PubMed ID: 21282357
[TBL] [Abstract][Full Text] [Related]
8. Epstein-Barr virus latent membrane protein 2A enhances MYC-driven cell cycle progression in a mouse model of B lymphoma.
Fish K; Chen J; Longnecker R
Blood; 2014 Jan; 123(4):530-40. PubMed ID: 24174629
[TBL] [Abstract][Full Text] [Related]
9. Epstein-Barr virus LMP2A imposes sensitivity to apoptosis.
Swanson-Mungerson M; Bultema R; Longnecker R
J Gen Virol; 2010 Sep; 91(Pt 9):2197-202. PubMed ID: 20484564
[TBL] [Abstract][Full Text] [Related]
10. Epstein-Barr Virus (EBV) LMP2A induces alterations in gene transcription similar to those observed in Reed-Sternberg cells of Hodgkin lymphoma.
Portis T; Dyck P; Longnecker R
Blood; 2003 Dec; 102(12):4166-78. PubMed ID: 12907455
[TBL] [Abstract][Full Text] [Related]
11. Spleen Tyrosine Kinase Inhibitor TAK-659 Prevents Splenomegaly and Tumor Development in a Murine Model of Epstein-Barr Virus-Associated Lymphoma.
Cen O; Kannan K; Huck Sappal J; Yu J; Zhang M; Arikan M; Ucur A; Ustek D; Cen Y; Gordon L; Longnecker R
mSphere; 2018 Aug; 3(4):. PubMed ID: 30135222
[TBL] [Abstract][Full Text] [Related]
12. Epstein-Barr virus (EBV) LMP2A mediates B-lymphocyte survival through constitutive activation of the Ras/PI3K/Akt pathway.
Portis T; Longnecker R
Oncogene; 2004 Nov; 23(53):8619-28. PubMed ID: 15361852
[TBL] [Abstract][Full Text] [Related]
13. Dasatinib therapy results in decreased B cell proliferation, splenomegaly, and tumor growth in a murine model of lymphoma expressing Myc and Epstein-Barr virus LMP2A.
Dargart JL; Fish K; Gordon LI; Longnecker R; Cen O
Antiviral Res; 2012 Jul; 95(1):49-56. PubMed ID: 22609829
[TBL] [Abstract][Full Text] [Related]
14. Epstein-Barr virus Latent Membrane Protein 2A (LMP2A)-mediated changes in Fas expression and Fas-dependent apoptosis: Role of Lyn/Syk activation.
Incrocci R; Hussain S; Stone A; Bieging K; Alt LA; Fay MJ; Swanson-Mungerson M
Cell Immunol; 2015 Oct; 297(2):108-19. PubMed ID: 26255694
[TBL] [Abstract][Full Text] [Related]
15. Epstein-Barr virus LMP2A enhances B-cell responses in vivo and in vitro.
Swanson-Mungerson M; Bultema R; Longnecker R
J Virol; 2006 Jul; 80(14):6764-70. PubMed ID: 16809282
[TBL] [Abstract][Full Text] [Related]
16. Epstein-Barr virus (EBV) LMP2A alters normal transcriptional regulation following B-cell receptor activation.
Portis T; Longnecker R
Virology; 2004 Jan; 318(2):524-33. PubMed ID: 14972521
[TBL] [Abstract][Full Text] [Related]
17. Epstein-Barr virus latent membrane protein 2A preferentially signals through the Src family kinase Lyn.
Rovedo M; Longnecker R
J Virol; 2008 Sep; 82(17):8520-8. PubMed ID: 18579586
[TBL] [Abstract][Full Text] [Related]
18. Epstein-Barr virus LMP2A alters in vivo and in vitro models of B-cell anergy, but not deletion, in response to autoantigen.
Swanson-Mungerson MA; Caldwell RG; Bultema R; Longnecker R
J Virol; 2005 Jun; 79(12):7355-62. PubMed ID: 15919890
[TBL] [Abstract][Full Text] [Related]
19. Epstein-Barr virus LMP2A increases IL-10 production in mitogen-stimulated primary B-cells and B-cell lymphomas.
Incrocci R; McCormack M; Swanson-Mungerson M
J Gen Virol; 2013 May; 94(Pt 5):1127-1133. PubMed ID: 23303827
[TBL] [Abstract][Full Text] [Related]
20. K1 and K15 of Kaposi's Sarcoma-Associated Herpesvirus Are Partial Functional Homologues of Latent Membrane Protein 2A of Epstein-Barr Virus.
Steinbrück L; Gustems M; Medele S; Schulz TF; Lutter D; Hammerschmidt W
J Virol; 2015 Jul; 89(14):7248-61. PubMed ID: 25948739
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
